ストックスクリーナーアプリを入手
136.99
4.03%
5.31
アフターアワーズ：
136.53
-0.46
-0.34%
Illumina Inc (ILMN) 最新ニュース
Trailblazing study shows early CGP leads to better precision treatments - Illumina
Connor Clark & Lunn Investment Management Ltd. Buys 114,466 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Myriad Genetics Announces Incorporation of its Proprietary - GlobeNewswire
Myriad Genetics Expands Illumina Partnership, Integrates Key Cancer Testing Technology | MYGN Stock News - StockTitan
(ILMN) Trading Report - Stock Traders Daily
Illumina's Moat in Sequencing Remains Narrow - Morningstar
Illumina gear up to expand TruSight Oncology portfolio - Yahoo Finance
ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio - Yahoo Finance
Gene Panel Market: Rapid Growth with Strong Future CAGR and Top - openPR
Victory Capital Management Inc. Has $16.48 Million Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Biological Multiplex Assays Market to Witness Significant - openPR
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
U.S. STOCKS Merck, Microstrategy, Illumina - XM
Illumina announces expansion of TruSight Oncology portfolio - PR Newswire
LMR Partners LLP Acquires Shares of 21,285 Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
RNA Sequencing Market Expected to Experience Positive Growth - openPR
NGS Based RNA Sequencing Market 2024 Analysis of Key Trends, - openPR
Digital Genome Market May See a Big Move | Illumina, GE Healthcare, Inscripta - openPR
How two systems integration scientists ensure a smooth workflow on MiSeq i100 - Illumina
Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Mutual of America Capital Management LLC - MarketBeat
CIBC Asset Management Inc Reduces Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
10 Best Immunotherapy Stocks to Buy Now - Insider Monkey
NGS & Microarray Training - Illumina
Impax Asset Management Group plc Increases Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
North America Bioinformatics Market Statistical Forecast - openPR
ING Groep NV Raises Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Plato Investment Management Ltd Raises Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Oppenheimer & Co. Inc. Has $5.33 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
DNA Test Kits Market Future Business Opportunities 2024-2031 | - openPR
Instrument Services - Illumina
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
12,000 Shares in Illumina, Inc. (NASDAQ:ILMN) Purchased by Freemont Management S.A. - MarketBeat
10,563 Shares in Illumina, Inc. (NASDAQ:ILMN) Bought by Entropy Technologies LP - MarketBeat
Illumina's SWOT analysis: ngs leader faces competition, aims for growth - Investing.com
Biochips Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Illumina's SWOT analysis: ngs leader faces competition, aims for growth By Investing.com - Investing.com UK
Urban Illumina 2024 at MDI Gurgaon Illuminates Insights, Entertainment, and Engagement through Disguised Market Research - Passionate In Marketing
Single-cell RNA analysis finds possible genetic drivers of bone cancer - Illumina
Mengis Capital Management Inc. Purchases New Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Consumer Genomics Industry Next Big Thing | Major Giants- Veritas, Illumina, Xcode Life - openPR
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
OVERSEA CHINESE BANKING Corp Ltd Sells 39,734 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina (NASDAQ:ILMN) Receives Equal Weight Rating from Morgan Stanley - MarketBeat
Baillie Gifford & Co. Lowers Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Bioinformatics Services Market: Size, Share, Trends, - openPR
Los Angeles Capital Management LLC Boosts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics - Insider Monkey
Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
WCM Investment Management LLC Has $424.48 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider - GlobeNewswire Inc.
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Piper Sandler Issues Pessimistic Forecast for Illumina (NASDAQ:ILMN) Stock Price - MarketBeat
Biological Multiplex Assays Market Report Analysis - openPR
Ownership Capital B.V. Sells 181,945 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Principal Financial Group Inc. Lowers Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Trend Tracker for (ILMN) - Stock Traders Daily
Carmel Capital Partners LLC Decreases Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Kornitzer Capital Management Inc. KS Has $2.75 Million Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Here’s Why You Should Invest in Illumina (ILMN) - Insider Monkey
Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ''Healthy China'' - PR Newswire
AIA Group Ltd Increases Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
NHS Wales partners with Illumina on genomics drive - pharmaphorum
Interpreting Illumina (ILMN) International Revenue Trends - Yahoo Finance
Q4 Earnings Estimate for Illumina Issued By Leerink Partnrs - MarketBeat
Radnor Capital Management LLC Invests $910,000 in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
0.88%
0.01%
大文字化:
|
ボリューム (24 時間):